We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01147523
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : January 20, 2012
Information provided by (Responsible Party):
Stergios A. Polyzos, Aristotle University Of Thessaloniki